This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Gilead Apollo, LLC. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Innovations of Xiaotian Wang in ACC Inhibition
Introduction
Xiaotian Wang is an accomplished inventor based in Foster City, CA (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that inhibit Acetyl CoA Carboxylase (ACC). His work is crucial for advancing treatments for ACC-mediated diseases.
Latest Patents
Wang holds a patent for "Solid forms of a thienopyrimidinedione ACC inhibitor and methods for production thereof." This invention provides solid forms of compounds that are useful as inhibitors of ACC, along with methods for their production and application in treating related diseases. His innovative approach has the potential to enhance therapeutic options for patients.
Career Highlights
Xiaotian Wang is currently employed at Gilead Apollo, LLC, where he continues to focus on research and development in the pharmaceutical sector. His expertise in ACC inhibition has positioned him as a valuable asset in the company’s mission to develop effective treatments.
Collaborations
Wang collaborates with notable colleagues, including Selcuk Calimsiz and Michael Geier. Their combined efforts contribute to the advancement of innovative solutions in the field of drug development.
Conclusion
Xiaotian Wang's contributions to ACC inhibition through his patented inventions highlight his role as a key innovator in the pharmaceutical industry. His work not only advances scientific knowledge but also holds promise for improving patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile